beta-D-Glc-(1->2)-[beta-D-Manp(1->3)]-D-Galp

Term ID

CHEBI:148425

Synonyms

(2S,3S,4S,5S,6R)-2-[(3R,4S,5S,6R)-2,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-4-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
beta-D-gluco-hexopyranosyl-(1->2)-[beta-D-manno-hexopyranosyl-(1->3)]-D-galacto-hexopyranose
beta-D-glucopyranosyl-(1->2)-[beta-D-mannopyranosyl-(1->3)]-D-galactopyranose
Glc(b1-2)[Man(b1-3)]Gal

Definition

A trisaccharide that is D-galactopyranose in which the hydroxy groups at positions 2 and 3 have been glycosylated by β-D-glucopyranosyl and β-D-mannopyranosyl groups, respectively.

References

glytoucan:G22418MB
kegg.glycan:G07752

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from beta-D-Glc-(1->2)-[beta-D-Manp(1->3)]-D-Galp

Phenotype where environments contain beta-D-Glc-(1->2)-[beta-D-Manp(1->3)]-D-Galp

Phenotype modified by environments containing beta-D-Glc-(1->2)-[beta-D-Manp(1->3)]-D-Galp

Phenotype affecting beta-D-Glc-(1->2)-[beta-D-Manp(1->3)]-D-Galp

Human Disease Model